The multiple sclerosis medication Zinbryta is relatively new to the market, approved by the U.S. Food and Drug Administration (FDA) just two years ago, but has already been linked with serious complications. Side effects of Zinbryta actually led to a market withdrawal of the medication earlier this year. Indeed, side effects of Zinbryta may be quite serious, even permanent or lasting in nature.

If you have suffered from side effects of Zinbryta, you may be able to pursue litigation and seek compensation.

Basics of Zinbryta

Zinbryta (also known by its generic name, daclizumab) is a multiple sclerosis medication manufactured by Biogen and AbbVie, and was granted FDA approval on May 27, 2016.

Multiple sclerosis (MS) is a brain disease that involves the immune system attacking and damaging the myelin coating that surrounds and protects the central nervous system. This can disrupt nerve signals to the brain, causing a slew of problems. The medication Zinbryta is used to treat relapsing MS, working to counteract the effects of the disease by binding to immune cells, reducing the cell activity of the attacking cells.

Unfortunately, a number of serious side effects of Zinbryta have been associated with the medication.

Side Effects of Zinbryta

While any medication will come with certain side effects, any complications associated with a drug must be included on its warnings. However, patients may not have been given adequate warning about some significant side effects of Zinbryta.

These serious side effects of Zinbryta include the brain condition encephalitis, the skin disease Stevens Johnson syndrome, and liver damage.

One of the most significant side effects associated with this drug is Zinbryta encephalopitis, or brain inflammation. Symptoms of Zinbryta encephalitis can be similar to those of the flu, including muscle pain, fatigue, fever, nausea or vomiting, irritability, light sensitivity, headache, seizures, and more.

The European Medicines Agency (EMA) has investigated 12 reports of major Zinbryta encephalitis. Three of the cases involved in the investigations eventually proved fatal.

Other major Zinbryta side effects include:

• Other immune reactions
• Liver failure and injury
• Stevens Johnson syndrome

Zinbryta Recall

After receiving reports from patients over side effects of Zinbryta, Biogren and Abbvie announced a recall on March 2, 2018, saying that they would be removing Zinbryta from the global market because of reports of side effects of Zinbryta.

The FDA has been made aware of the complications linked with Zinbryta, but the manufacturers’ recall was voluntary. The FDA has stated since the recall that it is now working closely with the manufacturers, Biogen and AbbVie, “to help ensure a well-organized withdrawal from the market in the United States, and to ensure that healthcare professionals have the information they need to carefully transition their patients using Zinbryta to another treatment.”

The FDA announced that “no new patients will start taking Zinbryta or participate in clinical studies,” and it will continue to be available for use as needed until April 30, 2018.

Filing a Zinbryta Lawsuit

If you or someone you love has suffered from side effects of Zinbryta like encephalitis, Stevens Johnson syndrome, or others, you may be able to file a lawsuit. Filing a lawsuit cannot take away the pain and suffering caused by side effects of Zinbryta, but it can help to alleviate the financial burden caused by medical expenses and lost wages.